Lonza and Shanghai Fosun Pharmaceutical form a Joint Venture to develop, manufacture and market generics in China

Lonza Group Ltd.

Switzerland / Tools, Services, and Manufacturing

$3,801.8m on 09/16/2011 [market cap]

Investor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Shanghai Fosun Pharmaceutical Group Co. Ltd.

China / Small-Cap Biopharma (<$1 billion)

Investor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced